RLYB: Rallybio Corporation Stock

by  •  • Comments Off on RLYB: Rallybio Corporation Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 29.34
Enterprise Value ($M) 15.43
Book Value ($M) 61.65
Book Value / Share 1.48
Price / Book 0.48
NCAV ($M) 61.39
NCAV / Share 1.48
Price / NCAV 0.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.93
Return on Assets (ROA) -0.50
Return on Equity (ROE) -0.54

Liquidity (mrq)
Quick Ratio 10.87
Current Ratio 10.87

Balance Sheet (mrq) ($M)
Current Assets 67.84
Assets 68.11
Liabilities 6.45
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.64
Operating Income -60.50
Net Income -57.77

Cash Flow Statement (mra) ($M)
Cash From Operations -49.28
Cash from Investing 33.49
Cash from Financing 5.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-12 13G/A Fmr Llc 4.30 -23.70
07-30 13G Johnson & Johnson 8.80
07-30 13G/A Canaan XI L.P. 4.97 -0.07

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-13 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-11-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-28 4,454 48,819 9.12
2025-03-27 25 13,427 0.19
2025-03-25 4,224 31,904 13.24

(click for more detail)

Similar Companies
RGNX – REGENXBIO Inc. RIGL – Rigel Pharmaceuticals, Inc.
RLMD – Relmada Therapeutics, Inc. ROIV – Roivant Sciences Ltd.
RPRX – Royalty Pharma plc


Financial data and stock pages provided by
Fintel.io